Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Pershing Square disclosed a single new equity position this quarter: Meta Platforms. The bet is large enough to tilt ...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
Block Inc. announced a sweeping AI-driven overhaul that cuts roughly 4,000 jobs, moving headcount from just over 10,0...
Marvell Technology is poised to release earnings later this week, with investors focused on AI chip orders and optica...
Microsoft led a rebound among the Magnificent 7 as investors rotated back into software, while Apple and Alphabet sli...
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
CF Industries has surged this year on supply constraints and cost advantages, yet a DOJ probe adds regulatory risk th...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
A top Interface executive dumped stock in a move worth hundreds of thousands. Is this a signal about the business or ...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...